Project Grant K08CA285952
Award Date
9/13/24
Completion Date
8/31/29
Dollars Obligated
$198K
Federal Agency
National Cancer Institute
Federal Grant Program
93.398
Assistance Type
Project Grant
Place of Performance
Boston, MA 02114, USA
Similar Awards
This federal Project Grant award from the National Cancer Institute (NCI), under the Cancer Detection and Diagnosis Research program (CFDA 93.394), provides $697,198 to the University of California, San Diego (UCSD) to develop a targeted colorectal cancer (CRC) screening strategy for adults aged 45-49. The study aims to: 1) characterize the acceptability of CRC screening in this age group and identify factors influencing screening uptake; and 2) conduct a randomized controlled trial to compare...
This $2,136,715 Project Grant award from the National Cancer Institute (NCI) under the Cancer Cause and Prevention Research program (CFDA 93.393) is focused on harnessing DNA methylation in peripheral blood to improve colorectal cancer prevention. The primary awardee, President and Fellows of Harvard College through its Harvard T.H. Chan School of Public Health, will lead the research effort. Key sub-awards have been made to Dana-Farber Cancer Institute and Boston University to contribute...
This $696,852 federal Project Grant award from the National Cancer Institute (CFDA 93.393 - Cancer Cause and Prevention Research) supports research to optimize a mobile messaging intervention for promoting colorectal cancer screening by fecal immunochemical tests (FIT) at community health centers (CHCs). The research, led by the Harvard T.H. Chan School of Public Health, will use a two-phase process to first focus on maximizing patient engagement through optimized text messaging, and then...
This $637,596 federal Project Grant award from the National Cancer Institute (CFDA 93.393 Cancer Cause and Prevention Research) will fund the development and testing of a video-based intervention to reduce defensive colorectal cancer information avoidance and increase screening uptake. The project will conduct a randomized controlled trial to evaluate the intervention's impact on screening intentions and uptake, with a focus on reaching individuals who tend to avoid colorectal cancer...
This federal Project Grant award from the National Cancer Institute (NCI), under the Cancer Cause and Prevention Research program (CFDA 93.393), will provide $547,047 to Georgetown University from May 1, 2025 to April 30, 2030. The project aims to test the bundling of multicancer screening and genetic services navigation to improve cancer health equity among non-Hispanic Black and Hispanic women. The intervention will be evaluated in two community breast cancer screening navigation programs...
This Project Grant award from the National Institute on Aging (CFDA 93.866 Aging Research) provides $625,452 to the Cleveland Clinic Lerner College of Medicine of Case Western Reserve University to develop and evaluate a clinical decision support intervention to guide colorectal cancer screening decisions in older adults. The project aims to incorporate considerations of patient life expectancy to improve screening recommendations, addressing a gap in current guidelines. A key collaborator on...
This $192,433 Project Grant award from the National Cancer Institute (NCI) under the Cancer Research Manpower (CFDA 93.398) program supports a research project to pilot an implementation strategy for increasing the use of mainstream genetic testing (MGT) for colorectal cancer (CRC) patients. The University of Alabama at Birmingham (UAB) will assess barriers to implementing MGT among healthcare providers and institutional stakeholders, as well as patient perceptions, to inform a multi-level...
This Project Grant award from the National Cancer Institute (NCI), under the Cancer Detection and Diagnosis Research program (CFDA 93.394), will support the development and clinical validation of an Optical Coherence Tomography (OCT) system and two specialized OCT imaging probes to enhance colorectal cancer screening. The $1,471,777 award to The General Hospital Corporation (doing business as Massachusetts General Hospital) aims to create an OCT system that can obtain 3D microscopic images of...
This Project Grant award from the National Cancer Institute (NCI), under the Cancer Cause and Prevention Research (CFDA 93.393) program, provides $753,446 to Boston Medical Center Corporation (BMC) to develop and evaluate an intervention to improve cervical cancer screening and follow-up rates in underserved populations. The "Development of Systems and Education for Cervical Cancer Prevention (DOSE-CC)" project aims to adapt BMC's successful HPV vaccination intervention model to...
This Project Grant award, in the amount of $269,942, was provided by the National Cancer Institute (NCI) under the Cancer Research Manpower (CFDA 93.398) federal grant program. The award aims to develop and pilot test a community health worker (CHW) intervention to improve lung cancer screening (LCS) uptake and address disparities in LCS among Black and Hispanic communities served by community health centers. The key products and services to be delivered include: 1) Jointly...